Brief: Genetic Signatures Says Public Health Wales Awards Enteric Testing Contract To Genetic Signatures
30/03/2022 02:24
March 30 (Reuters) - Genetic Signatures Ltd GSS.AX :
* PUBLIC HEALTH WALES AWARDS ENTERIC TESTING CONTRACT TO
GENETIC
SIGNATURES
* GENETIC SIGNATURES WINS NATIONAL TENDER FOR MOLECULAR
DETECTION
OF ENTERIC PATHOGENS FOR WALES
* CONTRACT HAS A VALUE OF UP TO A$1.8 MILLION PER ANNUM AND
ALSO
HAS AN OPTION TO EXTEND FOR 2 YEARS
Source text for Eikon: ID:nASX3ZqytH
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes